World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6542)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

185

HTML

2616

Figures (1-2)

525

Tables (1-1)

592

Sum=3918

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

338

Download

924

Sum=1262

Publishing Process of This Article

Item

Count

Browse

263

Download

866

Sum=1129

Apr 22, 2024 (publication date) through Apr 11, 2026

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Giri S, Anirvan P, Angadi S, Singh A, Lavekar A. Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease. World J Gastrointest Pathophysiol 2024; 15(1): 91100 [PMID: 38682026 DOI: 10.4291/wjgp.v15.i1.91100]
URL:	https://www.wjgnet.com/1007-9327/full/v15/i1/91100.htm

Number	Citing Articles
1	Priyankar Dey. The emerging phenotype of nonalcoholic fatty liver disease in lean individuals: what’s different?. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1693123
2	Rishi Chowdhary, Manjeet Kumar Goyal, Ashita Rukmini Vuthaluru, Megh Patel, Tanisha Sehgal, Kirti Arora, Rahul Chowdhary, Varun Mehta, Akash Batta, Omesh Goyal. Hepatic Outcomes in Lean Versus Nonlean Metabolic Dysfunction–Associated Steatotic Liver Disease: Propensity‐Matched Cohort Study. Hepatology Research 2026; doi: 10.1111/hepr.70158
3	Mohamed El-Kassas, Heba A. Othman, Mohamed Elbadry, Khalid Alswat, Yusuf Yilmaz. Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2025; 15(1): 102415 doi: 10.1016/j.jceh.2024.102415
4	Noha M. Gamil, Habiba A. Elsayed, Esraa T. Salah, Heba A. Mostafa, Riham A. El-Shiekh, Heba R. Ghaiad, Hebatollah E. Eitah. Decoding the mechanistic basis of liver–muscle communication in health and disease. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; doi: 10.1007/s00210-026-05015-3
5	Marwan S Al-Nimer. Sarcopenia and metabolic dysfunction-associated steatotic liver disease: The role of exercise-related biomarkers. World Journal of Hepatology 2025; 17(2): 101165 doi: 10.4254/wjh.v17.i2.101165 Abstract(379) \| Core Tip(419) \| Full Article(HTML)(1783) \| Full Article with Cover (PDF)-739K(143) \| Audio-1168K(10) \| Peer-Review Report-251K(81) \| Answering Reviewers-65K(75) \| Full Article (PDF)-544K(149) \| Full Article (XML)-64K(82) \| Times Cited (2) \| Total Visits (4820) \| Open
6	Jia-Lu Wang, Chao Wu, Li-Zhan Bie. Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study. World Journal of Hepatology 2025; 17(6): 107931 doi: 10.4254/wjh.v17.i6.107931 Abstract(231) \| Core Tip(243) \| Full Article(HTML)(1036) \| Full Article with Cover (PDF)-881K(75) \| Audio-142K(10) \| Peer-Review Report-203K(58) \| Answering Reviewers-178K(58) \| Full Article (PDF)-648K(96) \| Full Article (XML)-103K(57) \| Times Cited (1) \| Total Visits (4410) \| Open
7	Gregory Livshits, Nader Tarabeih, Alexander Kalinkovich, Adel Shalata, Shai Ashkenazi. Metabolic and Inflammatory Biomarkers Predicting Sarcopenic Obesity and Cardiometabolic Risk in Arab Women: A Cross-Sectional Study. International Journal of Molecular Sciences 2025; 26(12): 5699 doi: 10.3390/ijms26125699
8	Sizhe Wan, Mingkai Li, Wanjun Li, Yuexiang Ren, Yuankai Wu, Qingtian Luo, Wei Gong. Development and validation of a multimodal model integrating gut microbiota and metabolite for identifying sarcopenia in patients with MASLD: a study from two centers in China. Nutrition Journal 2025; 24(1) doi: 10.1186/s12937-025-01198-2
9	Inyoung Hwang, Shi-Ra Lee, Yun Kim, Sang Won Lee. Comparison of sarcopenia screening indices using serum creatinine and cystatin C in metabolic dysfunction-associated steatotic liver disease. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1633837
10	L. Yu. Ilchenko, V. A. Akhmedov, E. V. Vinnitskaya, E. I. Dedov, R. G. Myazin, I. G. Nikitin, A. S. Tikhomirova, I. E. Khoroshilov, G. V. Shavkuta, O. A. Ettinger, I. G. Adamova, L. B. Lazebnik. Sarcopenia in patients with non-alcoholic fatty liver disease: pathogenesis, diagnosis and treatment (expert opinion). Experimental and Clinical Gastroenterology 2026; (4): 3 doi: 10.31146/1682-8658-ecg-236-4-3-36
11	Fan Zhang, Longgen Liu, Wenjian Li. Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States. Nutrition Journal 2025; 24(1) doi: 10.1186/s12937-025-01081-0
12	V. A. Prikhodko, S. V. Okovityi. L-Ornithine salts as somatotropic axis modulators for the correction of sarcopenia in chronic liver disease. Meditsinskiy sovet = Medical Council 2025; (8): 80 doi: 10.21518/ms2025-223